We use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time. However, please note this may result in parts of the site no longer working correctly. If you continue without changing your settings we will assume you are happy to receive all cookies on this site.


Dr Bernadette Brennan

Consultant Paediatric Oncologist



Special Interests:

Soft tissue and Bone Sarcomas, Rare Tumours in Childhood, Late Effects of Childhood Cancer


Trained at St Andrews and Manchester Medical School and qualified as a Doctor in 1987. Trained in General Paediatrics in Queen’s Park Hospital Blackburn, St Mary’s Hospital, Booth Hall Children’s Hospital and RMCH from 1988 – 1992. Trained as a Paediatric and Adolescent Oncologist from 1992 – 1997 at the Royal Manchester Children’s Hospital and the Christie Hospital. During this time I obtained an MD in the Late Effects in Childhood ALL in Particular Osteoporosis and have published widely in the subject. I have a particular expertise in the later and the Late Endocrine Effects of Childhood Cancer. I have been enormously inspired in my career by 2 individuals Dr Sadhru Jivani who has sadly died, and Professor Steven Shalet my MD supervisor. I am currently Chair of the Soft Tissue Sarcoma group for the Children’s cancer and Leukaemia Group (CCLG), Chair of the CCLG Rare Tumour Group, Member of the Euro Ewing’s Study Group and CI for UK, Member of the European Soft tissue Sarcoma Group and CI for NRSTS study, and CCLG Bone Tumour Group.

Dr Brennan is an Honorary Senior Lecturer at The University of Manchester and an Honorary Consultant Paediatric Oncologist at The Christie.

She is an NCRI Sarcoma member; Bone subgroup member and YOSS subgroup chairman. She worked on the trial development for EE 2012, rEECUR, EpSSG RMS and NRSTS, and developed consortium at European level for the next generation of trials in synovial sarcoma and rhabdoid tumours

Dr Brennan is an EEC-Founder member and UK/International CI for EE2012. She devised, wrote protocol, obtained funding, managed and opened EE2012 trial; the PI of first European trial in relapsed Ewings with concomitant biology and sample collection and health economics.

She has given invited lectures for learned societies, trial, research groups both national and international in Synovial Sarcoma , Rhabdoid and Rare paediatric tumours - educational, promoting networks for trial development, guideline development

She has also produced multiple rare paediatric tumour guidelines for Orpa.net, CCLG and formed the basis of guideline development for the European rare tumour group ExPERT.

Dr Brennan's other roles include in Paediatric Cancer Services E04 CRG/NHS England Commissioning -Greater Manchester, Lancashire and South Cumbria Senate Rep; Clinical Director for Children's Pathway for the Manchester Cancer Services Provider Board and PTC Clinical Lead for CCL NCRN /National /international Paediatric Oncology Phase III trials.

Tel:0161 701 8430